Literature DB >> 25419077

Secretory carcinoma of breast in a patient treated for differentiated thyroid carcinoma-a diagnostic dilemma.

S Alagu Ganesh1, Madhu Muralee1, Renu Sukumaran2, M Iqbal Ahamed1.   

Abstract

Secretory carcinoma of the breast is a rare entity accounting for less than 1 % of all infiltrating breast carcinomas. Though initially considered as "juvenile breast carcinoma", due to its occurrence predominantly in pediatric population, it was later found to present in other age groups as well. We report a case of secretory carcinoma breast in a middle aged woman who had undergone treatment for papillary carcinoma of thyroid previously. The uniqueness of this malignancy and the diagnostic dilemma due to patient's past medical history, are discussed in detail.

Entities:  

Keywords:  Papillary carcinoma thyroid; Secretory carcinoma breast

Year:  2014        PMID: 25419077      PMCID: PMC4235870          DOI: 10.1007/s13193-014-0344-1

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  12 in total

Review 1.  Rare breast tumors: Review of the literature.

Authors:  Catalina Acevedo; Claudia Amaya; Jose-Luis López-Guerra
Journal:  Rep Pract Oncol Radiother       Date:  2013-09-27

Review 2.  Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature.

Authors:  Dali Li; Xiuying Xiao; Wentao Yang; Ruohong Shui; Xiaoyu Tu; Hongfen Lu; Daren Shi
Journal:  Mod Pathol       Date:  2011-12-09       Impact factor: 7.842

3.  Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.

Authors:  Cristina Tognon; Stevan R Knezevich; David Huntsman; Calvin D Roskelley; Natalya Melnyk; Joan A Mathers; Laurence Becker; Fatima Carneiro; Nicol MacPherson; Doug Horsman; Christopher Poremba; Poul H B Sorensen
Journal:  Cancer Cell       Date:  2002-11       Impact factor: 31.743

4.  Secretory carcinoma of the breast: results from the survival, epidemiology and end results database.

Authors:  David P Horowitz; Charu S Sharma; Eileen Connolly; Daniela Gidea-Addeo; Israel Deutsch
Journal:  Breast       Date:  2012-04-10       Impact factor: 4.380

5.  Secretory breast cancer in a 7.5-year old boy.

Authors:  J Szántó; C András; J Tsakiris; S Gomba; Z Szentirmay; S Bánlaki; I Szilágyi; C Kiss; P Antall; A Horváth; L Lengyel; M Castiglione-Gertsch
Journal:  Breast       Date:  2004-10       Impact factor: 4.380

6.  Secretory carcinoma of the breast.

Authors:  F A Tavassoli; H J Norris
Journal:  Cancer       Date:  1980-05-01       Impact factor: 6.860

7.  Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.

Authors:  Marick Laé; Paul Fréneaux; Xavier Sastre-Garau; Olfa Chouchane; Brigitte Sigal-Zafrani; Anne Vincent-Salomon
Journal:  Mod Pathol       Date:  2008-11-14       Impact factor: 7.842

8.  Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry.

Authors:  Raihanatou Diallo; Karl-Ludwig Schaefer; Agnes Bankfalvi; Thomas Decker; Monika Ruhnke; Pia Wülfing; Christian Jackisch; Jutta Luttges; Poul H B Sorensen; Meenakshi Singh; Christopher Poremba
Journal:  Hum Pathol       Date:  2003-12       Impact factor: 3.466

Review 9.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

10.  Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature.

Authors:  C Arce; D Cortes-Padilla; D G Huntsman; M A Miller; A Dueñnas-Gonzalez; A Alvarado; V Pérez; D Gallardo-Rincón; F Lara-Medina
Journal:  World J Surg Oncol       Date:  2005-06-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.